Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients (Q64046724)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients |
clinical trial |
Statements
A Phase Iii, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Efficacy And Safety Trial Of Bapineuzumab (Aab 001, Eln115727) In Subjects With Mild To Moderate Alzheimer Disease Who Are Apolipoprotein E 4 Carriers (English)
0 references
January 2008
0 references
October 2012
0 references
1,100
0 references
50 year
0 references
88 year
0 references